the pattern lately like for PANW AVGO SWKS SIG UTHR MDVN , they just love to give shorts a good squeezing. Only a fool wud have been short this into tonites expect a jerk up to 115 as wel, remember shorts to get out the first pullback. I will be shorting tomorrow, but thats my stategy, even PANW was shortable today twice fro 102s & later 101.75...so in the am expect a little pain.
its all SPY action from here, T is at 84, if it gets anywhere up near 88 short heavily,$6bil cap is full valued
who the #$%$ are u posting to dimwit? I shortd the cr@p out of the pop to $8, but in this market 6.30 was holding to. And try & supply links for the dilution news numb nuts
Gilead Announces Phase 3 Data Showing That the Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients with Chronic Hepatitis C in Japan
-- Interferon- and Ribavirin-Free Therapy Effective against Genotype 1 HCV, Japan’s Most Prevalent Strain of the Disease --
-- Japanese Regulatory Submission for Ledipasvir/Sofosbuvir Anticipated by Year End --
potential is not profits or revs, this was trading near $1bil market cap near 40 in premarkt, no way jose in this market...
cause they've been selling all flying bios, they ran the Banks today due to housing reports by KBH & LEN
This was such an easy short after ER 154 twice, 1/3 the revs of JAZZ & the same cap of 9bil, getting close to cover time
what do these cost again? tia
There was a 18.6M share Spot Secondary priced at 54c last sept done by Cowen, what ya talking about, they own plenty shares & clean up
So whats the added value here with FDA approval, in other words its already been marketed so factored in?